Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBionano Genomics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$7.56 | -$2.94 | -$4.50 |
| Q2 2025 | 1 | -$5.63 | -$2.19 | -$3.35 |
| Q3 2025 | 1 | -$4.32 | -$1.68 | -$2.57 |
| Q4 2025 | 1 | -$3.59 | -$1.40 | -$2.14 |
| Q1 2026 | 1 | -$5.04 | -$1.96 | -$3.00 |
| Q2 2026 | 1 | -$4.03 | -$1.57 | -$2.40 |
| Q3 2026 | 1 | -$3.02 | -$1.17 | -$1.80 |
| Q4 2026 | 1 | -$3.02 | -$1.17 | -$1.80 |
Bionano Genomics, Inc. Earnings Date And Information
Bionano Genomics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-19.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $18.95. The company had revenue of 6.07 M for the quarter and had revenue of 36.12 M for the year. Bionano Genomics, Inc. has generated $-7 earnings per share over the last year ($-6.81 diluted earnings per share) and currently has a price-to-earnings ratio of -2.1. Bionano Genomics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Bionano Genomics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.21 | -$0.52 | -0.31 | $7.76 M | $6.07 M |
| 08/07/2024 | Q2 2024 | -$0.42 | -$0.24 | 0.18 | $8.02 M | $7.77 M |
| 05/08/2024 | Q1 2024 | -$0.64 | -$0.60 | 0.04 | N/A | $8.77 M |
| 03/05/2024 | Q4 2023 | -$0.87 | -$0.96 | -0.09 | N/A | $10.72 M |
| 11/08/2023 | Q3 2023 | -$44.91 | -$3.22 | 41.69 | $9.08 M | $9.32 M |
| 08/09/2023 | Q2 2023 | -$53.89 | -$1.24 | 52.65 | $8.29 M | $8.66 M |
| 05/09/2023 | Q1 2023 | -$53.89 | -$1.23 | 52.66 | N/A | $7.42 M |
| 03/09/2023 | Q4 2022 | -$53.89 | -$1.30 | 52.59 | N/A | $8.22 M |
| 11/03/2022 | Q3 2022 | -$71.86 | -$1.10 | 70.76 | $6.79 M | $7.22 M |
| 08/04/2022 | Q2 2022 | -$59.88 | -$1.13 | 58.75 | $6.28 M | $6.67 M |
| 05/05/2022 | Q1 2022 | -$47.90 | -$1.05 | 46.85 | N/A | $5.70 M |
| 03/01/2022 | Q4 2021 | -$41.92 | -$0.81 | 41.11 | N/A | $6.30 M |
| 11/04/2021 | Q3 2021 | -$35.93 | -$0.74 | 35.19 | $4.22 M | $4.66 M |
| 08/04/2021 | Q2 2021 | -$29.94 | -$0.70 | 29.24 | $3.50 M | $3.86 M |
| 05/13/2021 | Q1 2021 | -$29.94 | -$0.38 | 29.56 | N/A | $3.17 M |
| 03/23/2021 | Q4 2020 | -$35.93 | -$1.13 | 34.8 | N/A | $3.99 M |
| 11/12/2020 | Q3 2020 | -$35.93 | -$0.81 | 35.12 | $2.07 M | $2.20 M |
| 08/13/2020 | Q2 2020 | -$53.89 | -$0.89 | 53 | $863,000 | $1.18 M |
| 06/18/2020 | Q1 2020 | -$131.74 | -$2.95 | 128.79 | N/A | $1.14 M |
| 03/10/2020 | Q4 2019 | N/A | -$2.83 | N/A | N/A | $2.79 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bionano Genomics, Inc. Earnings: FAQ's
Bionano Genomics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based offlast year's report dates.
The conference call for Bionano Genomics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Bionano Genomics, Inc.'s latest earnings report can be read online.
Bionano Genomics, Inc. (:BNGO) has a recorded annual revenue of $36.12 M.
Bionano Genomics, Inc. (:BNGO) has a recorded net income of $-232,493,000.Bionano Genomics, Inc. has generated $-6.81 earnings per share over the last four quarters.
Bionano Genomics, Inc. (:BNGO) has a price-to-earnings ratio of -2.1 and price/earnings-to-growth ratio is -0.04.